BRIDGE

OFFICIAL TITLE: PHASE II TRIAL OF DURVALUMAB AND CHEMOTHERAPY INDUCTION FOLLOWED BY DURVALUMAB AND RADIOTHERAPY IN LARGE VOLUME STAGE III NSCLC (THE BRIDGE STUDY).

PROJECT DETAILS

STAGE III A-B-C (ACCORDING TO VERSION 8 OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER STAGING MANUAL IN THORACIC ONCOLOGY) NSCLC PATIENTS NOT ELIGIBLE FOR SURGERY OR CONCURRENT CHEMORADIATION AT DIAGNOSIS BECAUSE OF LARGE TUMOR VOLUMES.
THIS IS A MULTICENTRIC, OPEN LABEL, SINGLE ARM, SIMON 2 STAGES PHASE 2 TRIAL. 

BRIDGE AT CLINICALTRIALS.GOV

TUMOR TYPE

PHASE

NSCLC

II

65

3

Spain, France, Italy.

N

SITES

COUNTRY

STATUS

Start-up

BRIDGE SITES

SPAIN

Vall d'Hebron Institute of Oncology (VHIO)

FRANCE

Gustave Roussy

ITALY

Institute Tumori Mario Negrini